Yoram Reiter

5.8k citations

107 papers · 4.4k indexed · h-index 41

Immunology top 0.5%
- Immunotherapy and Immune Responses 38
- T-cell and B-cell Immunology 37
- Immune Cell Function and Interaction 29
- Toxin Mechanisms and Immunotoxins 24
Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research 45
Oncology top 2%
- CAR-T cell therapy research 21
Biotechnology top 1%
Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 12
- Protein purification and stability 8

Co-authors: Ira Pastan Galit Denkberg Ulrich Brinkmann Cyril J. Cohen Zvi Fishelson Avital Lev Eynav Klechevsky Jacques Banchereau
Cited by: Immunology Radiology, Nuclear Medicine and Imaging Oncology
Journals: Proceedings of the National Academy of Sciences (5 papers)Journal of Biological Chemistry (1 paper)The Journal of Experimental Medicine (2 papers)
Partner nations: Israel United States United Kingdom

In The Last Decade

Yoram Reiter

107 papers receiving 4.3k citations

Peers

Countries citing papers authored by Yoram Reiter

Since Specialization

Citations

This map shows the geographic impact of Yoram Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoram Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoram Reiter more than expected).

Fields of papers citing papers by Yoram Reiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoram Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoram Reiter. The network helps show where Yoram Reiter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoram Reiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoram Reiter Line = papers co-authored together Yoram Reiter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Harnessing antibody-mediated recognition of the intracellular proteome with T cell receptor-like specificity Frontiers in Immunology ·Maya Haus‐Cohen,Yoram Reiter	2024	1
2	Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes Nano Letters ·Arbel Artzy‐Schnirman,Enas Abu‐Shah,Rona Chandrawati,Efrat Altman,Norkhairin Yusuf,Shih‐Ting Wang,José Alberto Carlos Ramos,Catherine S. Hansel,Maya Haus‐Cohen,Rony Dahan,Sefina Arif,Michael L. Dustin,Mark Peakman,Yoram Reiter,Molly M. Stevens	2022	2
3	Phenotypic Models of CAR T-Cell Activation Elucidate the Pivotal Regulatory Role of CAR Downmodulation Molecular Cancer Therapeutics ·Raanan Greenman,Yoav Pizem,Maya Haus‐Cohen,Guy Horev,Galit Denkberg,Shai S. Shen-Orr,Jacob Rubinstein,Yoram Reiter	2021	13
4	Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity Cancer Immunology Research ·Yasmin Leshem,James O'Brien,Xiufen Liu,Tapan K. Bera,Masaki Terabe,Jay A. Berzofsky,Birgit Bossenmaier,Gerhard Niederfellner,Chin‐Hsien Tai,Yoram Reiter,Ira Pastan	2017	39
5	MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells Cancer Research ·Dina Stroopinsky,Jacalyn Rosenblatt,Keisuke Ito,Heidi Mills,Li Yin,Hasan Rajabi,Baldev Vasir,Turner Kufe,Katarina Luptakova,Jon Arnason,Caterina Nardella,James D. Levine,Robin Joyce,Ilene Galinsky,Yoram Reiter,Richard M. Stone,Pier Paolo Pandolfi,Donald Küfe,David Avigan	2013	41
6	Mixed Alkanethiol Monolayers on Submicrometric Gold Patterns: A Controlled Platform for Studying Cell–Ligand Interactions Nano Letters ·Rami Fishler,Arbel Artzy‐Schnirman,Elad Peer,Ron Wolchinsky,R. Brener,Tova Waks,Zelig Eshhar,Yoram Reiter,Uri Sivan	2012	11
7	TCR‐like antibodies distinguish conformational and functional differences in two‐ versus four‐domain auto reactive MHC class II–peptide complexes European Journal of Immunology ·Rony Dahan,Moran Tabul,Yuan K. Chou,Roberto Meza‐Romero,Shayne F. Andrew,Adolph J. Ferro,Gregory G. Burrows,Halina Offner,Arthur A. Vandenbark,Yoram Reiter	2011	12
8	Expression Hierarchy of T Cell Epitopes from Melanoma Differentiation Antigens: Unexpected High Level Presentation of Tyrosinase-HLA-A2 Complexes Revealed by Peptide-Specific, MHC-Restricted, TCR-Like Antibodies The Journal of Immunology ·Yael Michaeli,Galit Denkberg,Keren Sinik,Liz Lantzy,Chiang Chih-Sheng,Celine Beauverd,Tamar Ziv,Pedro Romero,Yoram Reiter	2009	40
9	Cutting Edge: MHC Class I–Ly49 Interaction Regulates Neuronal Function The Journal of Immunology ·Ofer Zohar,Yoram Reiter,Jack R. Bennink,Avital Lev,Sebastiano Cavallaro,Sabrina Paratore,Chaim G. Pick,Gary Brooker,Jonathan W. Yewdell	2008	38
10	The Influence of a Human Embryonic Stem Cell–Derived Microenvironment on Targeting of Human Solid Tumor Xenografts Cancer Research ·Maty Tzukerman,Tzur Rosenberg,Irena Reiter,Shoshana Ben-Eliezer,Galit Denkberg,Raymond Coleman,Yoram Reiter,Karl Skorecki	2006	35
11	Vascular Endothelial Cells Have Impaired Capacity to Present Immunodominant, Antigenic Peptides: A Mechanism of Cell Type-Specific Immune Escape The Journal of Immunology ·Marco Kummer,Avital Lev,Yoram Reiter,Barbara Biedermann	2005	18
12	Increased Expression of Human T Lymphocyte Virus Type I (HTLV-I) Tax11-19 Peptide–Human Histocompatibility Leukocyte Antigen A201 Complexes on CD4+ CD25 + T Cells Detected by Peptide-specific, Major Histocompatibility Complex–restricted Antibodies in Patients with HTLV-I–associated Neurologic Disease The Journal of Experimental Medicine* ·Yoshihisa Yamano,Cyril J. Cohen,Norihiro Takenouchi,Karen Yao,Utano Tomaru,Hongchuan Li,Yoram Reiter,Steven Jacobson	2004	83
13	Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies The Journal of Immunology ·Cyril J. Cohen,Offra Sarig,Yoshihisa Yamano,Utano Tomaru,Steven Jacobson,Yoram Reiter	2003	59
14	Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes The Journal of Immunology ·William E. Biddison,Richard V. Turner,Susan J. Gagnon,Avital Lev,Cyril J. Cohen,Yoram Reiter	2003	34
15	Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen The Journal of Immunology ·Galit Denkberg,Avital Lev,Lea Eisenbach,Itai Benhar,Yoram Reiter	2003	49
16	Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions Journal of Molecular Recognition ·Cyril J. Cohen,Galit Denkberg,Avital Lev,Malka Epel,Yoram Reiter	2003	46
17	Modification of a Tumor-Derived Peptide at an HLA-A2 Anchor Residue Can Alter the Conformation of the MHC-Peptide Complex: Probing with TCR-Like Recombinant Antibodies The Journal of Immunology ·Galit Denkberg,Eynav Klechevsky,Yoram Reiter	2002	40
18	Recruitment of CTL Activity by Tumor-Specific Antibody-Mediated Targeting of Single-Chain Class I MHC-Peptide Complexes The Journal of Immunology ·Avital Lev,Hila Novak,Dina Segal,Yoram Reiter	2002	16
19	Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR The Journal of Immunology ·Galit Denkberg,Cyril J. Cohen,Yoram Reiter	2001	68
20	Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment Journal of Biological Chemistry ·Yoram Reiter,Ulrich Brinkmann,Sun-Hee Jung,B. Lee,Philip G. Kasprzyk,C. Richter King,Ira Pastan	1994	81

About Yoram Reiter

Yoram Reiter is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 107 papers that have together received 4.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (45 papers), Immunotherapy and Immune Responses (38 papers), T-cell and B-cell Immunology (37 papers), Immune Cell Function and Interaction (29 papers), Toxin Mechanisms and Immunotoxins (24 papers), CAR-T cell therapy research (21 papers), Glycosylation and Glycoproteins Research (12 papers) and Protein purification and stability (8 papers). The work is most often cited by research in Immunology (3.0k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Oncology (1.3k citations). Yoram Reiter has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Ira Pastan, Galit Denkberg, Ulrich Brinkmann, Cyril J. Cohen, Zvi Fishelson, Avital Lev, Eynav Klechevsky, Jacques Banchereau, Gérard Zurawski and LuAnn Thompson-Snipes. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact